Cost-Effectiveness Analysis of Hepatic Arterial Infusion of FOLFOX Combined Sorafenib for Advanced Hepatocellular Carcinoma With Portal Vein Invasion

BACKGROUND: Hepatic arterial infusion (HAI) of oxaliplatin, leucovorin, and fluorouracil (FOLFOX) plus sorafenib has a more desirable effect versus sorafenib for hepatocellular carcinoma (HCC) patients with portal vein invasion. However, considering the high cost of hepatic arterial infusion of chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Meiyue, Lin, Shen, Wilson, Leslie, Huang, Pinfang, Wang, Hang, Lai, Shubin, Dong, Liangliang, Xu, Xiongwei, Weng, Xiuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985441/
https://www.ncbi.nlm.nih.gov/pubmed/33767976
http://dx.doi.org/10.3389/fonc.2021.562135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985441/
https://www.ncbi.nlm.nih.gov/pubmed/33767976
http://dx.doi.org/10.3389/fonc.2021.562135

Ejemplares similares